- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03950934
Videolaryngoscopic Intubation and Difficult Airway Classification (VIDiAC)
Classification and Prediction of Difficult Videolaryngoscopic Intubation in Patients Undergoing Oral and Maxillofacial or Ear, Nose and Throat Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Difficult endotracheal intubation is a major reason for anesthesia related adverse events. Videolaryngoscopy has become an important part of the anesthesiological standard of care for difficult airway management in the past decades. Still, medical preconditions, as well as procedural and technical factors related with difficult videolaryngoscopy have not been systematically investigated, and a standardized comprehensive classification system for the severity of videolaryngoscopic intubation has yet to be specified. The primary objective of this study is to identify independent factors associated with difficult videolaryngoscopic intubation in patients undergoing ENT or OMF surgery.
Patients with conditions of the ENT and OMF spectrum have a predisposition for difficult airway management and are at high risk for adverse events during endotracheal intubation. However, current recommendations for preoperative screening for difficult intubation rarely consider space consuming lesions of the laryngopharyngeal region. Comprehensive data identifying the predictive value of preoperative flexible nasal videoendoscopy as a diagnostic measure to anticipate difficult airway management still lack. Thus, secondary aim of this study is to evaluate the diagnostic value and clinical significance of preoperative flexible nasal videoendoscopy to predict difficult videolaryngoscopic intubation in these patients.
Study design:
The investigators conduct a prospective observational study, which includes 400 patients with predicted difficult airway and confirmed indication for flexible nasal videoendoscopy and videolaryngoscopic intubation undergoing ENT or OMF surgery.
Procedural and surgical data as well as medical preconditions will be assessed systematically. The handling anesthetist and two independent observers will be surveyed (structured questionnaire) in order to assess procedural and technical factors related with videolaryngoscopic intubation.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Hamburg, Germany, 20246
- University Medical Center Hamburg-Eppendorf
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion criteria:
- 18 Years and older
- Patients scheduling for ENT or OMF surgery under general anesthesia with requirement of endotracheal Intubation
- Risk of difficult airway management with confirmed indication for videolaryngoscopic intubation
Exclusion criteria:
- No consent given
- Pregnancy
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difficult videolaryngoscopic intubation
Time Frame: 30 minutes after endotracheal intubation
|
Questionnaire
|
30 minutes after endotracheal intubation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Successful first intubation attempt
Time Frame: 30 minutes after endotracheal intubation
|
Observation during airway management
|
30 minutes after endotracheal intubation
|
|
Overall success
Time Frame: 30 minutes after endotracheal intubation
|
Observation during airway management
|
30 minutes after endotracheal intubation
|
|
Unsuccessful videolaryngoscopy
Time Frame: 30 minutes after endotracheal intubation
|
Observation during airway management
|
30 minutes after endotracheal intubation
|
|
Severity of videolaryngoscopic intubation
Time Frame: 30 minutes after endotracheal intubation
|
Numeral rating scale
|
30 minutes after endotracheal intubation
|
|
Specific recommendations of the handling anesthetist
Time Frame: 30 minutes after endotracheal intubation
|
Questionnaire
|
30 minutes after endotracheal intubation
|
|
Time to successful intubation
Time Frame: 30 minutes after endotracheal intubation
|
Observation during airway management
|
30 minutes after endotracheal intubation
|
|
Number of laryngoscopy and intubation attempts
Time Frame: 30 minutes after endotracheal intubation
|
Observation during airway management
|
30 minutes after endotracheal intubation
|
|
Lowest oxygen saturation during airway management
Time Frame: 30 minutes after endotracheal intubation
|
Observation during airway management
|
30 minutes after endotracheal intubation
|
|
Initial end-tidal carbon dioxide level after successful intubation
Time Frame: 30 minutes after endotracheal intubation
|
Observation during airway management
|
30 minutes after endotracheal intubation
|
|
Observed complications during or after induction of general anesthesia
Time Frame: 30 minutes after endotracheal intubation
|
Questionnaire
|
30 minutes after endotracheal intubation
|
|
Length of hospital stay
Time Frame: Until hospital discharge up to 3 months after surgery
|
Follow-up
|
Until hospital discharge up to 3 months after surgery
|
|
All cause in-hospital mortality
Time Frame: Until hospital discharge up to 3 months after surgery
|
Follow-up
|
Until hospital discharge up to 3 months after surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Martin Petzoldt, PD Dr., Department of Anesthesiology, University Medical Center Hamburg-Eppendorf
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PV5856
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.